[Heparin-induced thrombosis-thrombocytopenia syndrome in Crohn disease. Further thromboses with oral anticoagulation after discontinuation of heparin].
Eisenlohr
H
H
Medizinische Klinik, Krankenhaus des Landkreises Starnberg, Akademisches Lehrkrankenhaus, Ludwig Maximilians Universität München.
Trenkwalder
P
P
Lydtin
H
H
D000284:Administration, Oral; D001780:Blood Coagulation Tests; D003424:Crohn Disease / Q000097:blood* / Q000188:drug therapy; D004359:Drug Therapy, Combination; D005260:Female; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D010644:Phenprocoumon / Q000008:administration & dosage / Q000009:adverse effects*; D010976:Platelet Count / Q000187:drug effects; D011241:Prednisone / Q000008:administration & dosage; D011655:Pulmonary Embolism / Q000097:blood / Q000139:chemically induced*; D013375:Substance Withdrawal Syndrome / Q000097:blood*; D012460:Sulfasalazine / Q000008:administration & dosage; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced*; D013924:Thrombophlebitis / Q000097:blood / Q000139:chemically induced*
D012460:Sulfasalazine; D006493:Heparin; D010644:Phenprocoumon; D011241:Prednisone
Heparininduziertes Thrombose-Thrombozytopenie-syndrom bei M. Crohn. Weitere Thrombosen unter oraler Antikoagulation nach Absetzen von Heparin.